LGR5 positivity defines stem-like cells in colorectal cancer.
about
Cancer stem cells--important players in tumor therapy resistanceUse of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated CancerWhat Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer TissueTargeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study.Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-βClaudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis.Emerging understanding of multiscale tumor heterogeneityThe river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacityERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal CancerTranscriptome profiling of LGR5 positive colorectal cancer cells.ERBB4 is over-expressed in human colon cancer and enhances cellular transformationHeterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells.Critical role of microbiota within cecal crypts on the regenerative capacity of the intestinal epithelium following surgical stress.LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiationBrachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer.BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk.Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer.LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.Cancer stem cells in human digestive tract malignancies.FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.The third dimension: new developments in cell culture models for colorectal research.MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.LGR5 promotes the proliferation of colorectal cancer cells via the Wnt/β-catenin signaling pathway.Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas.PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.An Overview of Lipid Droplets in Cancer and Cancer Stem Cells.Obesity promotes colonic stem cell expansion during cancer initiation.LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates.Cancer stem cell surface markers on normal stem cells.Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells.
P2860
Q26823015-6404A79A-8FB6-40B9-BFAB-1F172DBC502BQ28079356-554EBCDF-B69E-4355-8503-73E8B3E0A015Q28552232-A0289E93-1B20-498C-A9AB-40A2980E7D0EQ33616786-B2B72400-3168-4F9E-822D-CEBBFA8312E6Q33694667-AA2E9EF9-1E62-41E8-90EC-7A96625D0234Q33928256-783C33A9-F8D6-4253-8916-CFBDD0C27D46Q34730000-3EEB3E09-DCEC-4F29-B418-DB7D7386F922Q34880355-212A0744-0724-42D2-B016-13860BD9F380Q35172310-24AD38E3-B7E1-49A5-871E-7023BB0371ABQ35632597-607B9A70-3246-4730-A1BC-31C0A4E59E6CQ35772903-AF3E7C3B-EB76-4C2A-A7A4-678875414F84Q35849680-932C711D-15D7-42A4-9AA8-4CD2D69021B6Q35951773-03EFE8CD-BEDA-4BA4-8319-4A5D2040C58AQ36067899-EC1E566E-4185-41D1-9635-FE55318276EFQ36165598-F7563428-DF6D-4253-B1FC-7EC3AE387CF6Q36195433-70AFA968-FC7E-41B5-A559-331FA4FE1379Q36225836-BE717CDE-189A-45A6-A7C1-A6F6047D404AQ36605121-2465BB00-2756-436E-A733-474B2395DCDFQ36771749-7A73819B-5404-4E57-8F1D-3EC47D4F79B1Q36998280-292C5E1C-9675-4527-9144-661227514BBBQ37237764-2341FFF4-A1A6-4D61-BC3E-631050381EB7Q37603293-EE7D5CAF-0461-403A-80A9-5DE1D5B96144Q37649057-CB15709E-EA65-40B0-B6BB-2BD7882ACF65Q37697137-786371F8-6300-4374-BA3D-1AC46F7B6956Q37699315-C90ACF4E-ADC8-4B69-BBBF-8F5D460AC4AEQ38261762-5FDBC2BC-DE5C-4D48-A83E-43962A047DEFQ38601789-9D129716-FBAC-49F1-BC76-62F53CB66B33Q38603133-0712DF6F-37AF-45CF-AF84-E777744FA9E5Q38773122-1CCA4A26-C25C-4EF4-8506-5A6D68DAB955Q38851568-5D6B35F5-B2A7-4025-BE0B-B8FC8C0E1DDBQ38857274-36B5A920-4FCE-46DB-9E17-E044A1773E7DQ38899681-3C353310-0606-416E-BDC9-9E164F1FC1DDQ40509393-D3A20A74-A528-4A38-977F-9688E9D03743Q41528938-24A8C1FB-8BEB-4922-88AC-59CD4F1ECF6CQ42076725-B6259017-94AA-48C8-82AC-32002C38B407Q42261483-92AFC361-921B-417E-A7A5-EBA7AFC7E724Q42330832-49F2D8D8-198A-4856-9787-32FC8AF65A66Q42332008-6ADCB372-1B22-4131-B4FD-C7E9453FF0CDQ42378297-D05BFFED-6688-41FC-8DAA-7C0764450F98Q43153685-CEE8309B-FF30-4003-8210-B33B80BE050C
P2860
LGR5 positivity defines stem-like cells in colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
LGR5 positivity defines stem-like cells in colorectal cancer.
@en
LGR5 positivity defines stem-like cells in colorectal cancer.
@nl
type
label
LGR5 positivity defines stem-like cells in colorectal cancer.
@en
LGR5 positivity defines stem-like cells in colorectal cancer.
@nl
prefLabel
LGR5 positivity defines stem-like cells in colorectal cancer.
@en
LGR5 positivity defines stem-like cells in colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
LGR5 positivity defines stem-like cells in colorectal cancer.
@en
P2093
Hans Clevers
Jordi Camps
Katherine McKinnon
Nick Barker
Nicole McNeil
Thomas Ried
Timo Gaiser
P2860
P304
P356
10.1093/CARCIN/BGT377
P407
P577
2013-11-26T00:00:00Z